Vomiting · women seeking emergency contraception
Ulipristal acetate (all doses) showed no clear difference in specific side effects ‐ vomiting compared with levonorgestrel (moderate certainty).
1 finding from 1 review
Specific side effects ‐ spotting/bleeding after treatment · women seeking emergency contraception
Ulipristal acetate (all doses) showed no clear difference in specific side effects ‐ spotting/bleeding after treatment compared with levonorgestrel (moderate certainty).
1 finding from 1 review
Menses ‐ early · women seeking emergency contraception
Ulipristal acetate (all doses) probably leads to lower menses ‐ early compared with levonorgestrel (moderate certainty).
1 finding from 1 review
Menses ‐ delay · women seeking emergency contraception
Ulipristal acetate (all doses) leads to higher menses ‐ delay compared with levonorgestrel (high certainty).
1 finding from 1 review
Observed number of pregnancies (all women) · women seeking emergency contraception
Mid‐dose mifepristone (25 mg‐50 mg) probably leads to lower observed number of pregnancies (all women) compared with levonorgestrel 1.5 mg (moderate certainty).
1 finding from 1 review
Side effects · women seeking emergency contraception
Mid‐dose mifepristone (25 mg‐50 mg) may leads to lower any side effect compared with levonorgestrel 1.5 mg (low certainty).
1 finding from 1 review
Menstrual blood loss PBAC score · heavy menstrual bleeding
1 finding from 1 review
Menstrual blood loss: improvement in mean blood loss (PBAC score < 100) · heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes menstrual blood loss: improvement in mean blood loss (PBAC score <… compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Adverse events (any) · heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes adverse events (any) compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Thromboembolic events · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall pain at 12 months  · Patients with symptomatic endometriosis following surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Chronic pelvic pain at 12 months Â
1 finding from 1 review
Dysmenorrhoea at 12 months Â
1 finding from 1 review
Improvement of the most troublesome symptom at 12 months Â
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life at 12 months Â
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient satisfaction at 12 monthsÂ
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events Â
1 finding from 1 review
Chronic pelvic pain at 12 months  · Patients with symptomatic endometriosis following surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dysmenorrhoea at 12 months  · Patients with symptomatic endometriosis following surgery
1 finding from 1 review
no estimate extracted
95 participants
Very low
Improvement of the most troublesome symptom at 12 months  · Patients with symptomatic endometriosis following surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found